Overview Dexamethasone Efficacy in HELLP I Syndrome Status: Unknown status Trial end date: 2012-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the efficacy of dexamethasone for treatment of HELLP I (hemolysis, elevated liver enzymes and low platelet count) syndrome. Phase: Phase 3 Details Lead Sponsor: Universidad del Valle, ColombiaTreatments: BB 1101DexamethasoneDexamethasone 21-phosphateDexamethasone acetate